Anti-Recombinant-SARS-CoV-2 Spike RBD antibody [79C3] (STJA0002933)
SPECIFICATIONS
ClonalityMonoclonal
HostCHO cells
ConjugationUnconjugated
IsotypeIgG kappa
ImmunogenRecombinant SARS-CoV-2 RBD protein produced by CHO-based proprietary suspension cell line.
General Information
| Short Description | Cho Cells monoclonal anti-Recombinant-SARS-CoV-2 Spike RBD for use in ELISA in SARS-CoV-2 samples. Datasheet included with dilution recommendations, and related reagents. |
| Applications | ELISA |
| Host | CHO cells |
| Reactivity | SARS-CoV-2 |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Clonality | Monoclonal |
| Clone ID | 79C3 |
| Isotype | IgG kappa |
| Conjugation | Unconjugated |
| Purification | Protein A affinity chromatography following gel filtration |
| Dilution Range | Indirect ELISA 0.01 – 0.02 ng/ml |
| Formulation | PBS pH 7.4 |
| Storage Instruction | The product is stable at 4 °C for several days. Store at-20 °C to-70 °C long term. Avoid multiple freeze-thaw cycles. |
| Dissociation Constant | <1.0 x 10-12 M (measured against SARS-CoV-2 Trimeric Spike protein) 6.9 x 10-9 M (measured against SARS-CoV-2 Spike S1 protein) |
Target Information
| Immunogen | Recombinant SARS-CoV-2 RBD protein produced by CHO-based proprietary suspension cell line. |
| Specificity | SARS-CoV-2 Spike RBD Neutralizing properties: blocks S1 and ACE2 binding in Octet system. |